Renalytix Ai is a biotechnology company focused on developing innovative diagnostic solutions for kidney diseases
By leveraging advanced artificial intelligence and machine learning technologies, the company aims to improve the early detection, diagnosis, and management of kidney-related conditions. Their proprietary products analyze patient data to provide healthcare professionals with actionable insights that enhance patient outcomes. Renalytix Ai's mission is to transform the care of kidney disease through the application of advanced analytics, ultimately aiming to reduce the burden of such diseases on patients and healthcare systems.
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.
Shares of Paymentus Holdings, Inc. (NYSE: PAY) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth quarter financial results.
U.S. stocks traded lower toward the end of trading, with the S&P 500 edging lower on Monday. The Dow traded down 0.20% to 39,007.30 while the NASDAQ fell 0.18% to 16,245.77. The S&P 500 also fell, dropping, 0.01% to 5,137.05.
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its SEAL01 Bitcoin mining chip and amid overall strength in the price of Bitcoin.
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 0.2% on Monday. The Dow traded down 0.25% to 38,988.86 while the NASDAQ fell 0.18% to 16,245.30. The S&P 500 also fell, dropping, 0.06% to 5,134.05.
Renalytix evaluates acquisition offer from a strategic diagnostics company. Board initiates formal sale process. FDA-approved KidneyIntelX.dkd included in Governmentwide Acquisition Contract. Stock surges 40%
